Condition

q11.2) clinical trials and research

• 5Clinical trials
• 1Country

Newest q11.2) clinical trials

All recruiting trials (5)

• Dose‑adjusted EPOCH chemotherapy with or without rituximab plus ponatinib for newly diagnosed Philadelphia chromosome–positive B‑cell ALL/lymphoblastic lymphoma

  This treatment plan tests whether adding the BCR‑ABL inhibitor ponatinib to dose‑adjusted EPOCH chemotherapy, with rituximab for CD20‑positive disease, helps adults newly diagnosed with Philadelphia chromosome–positive B‑cell acute lymphoblastic leukemia or lymphoblastic lymphoma.

  Recruiting Phase 2 University of Washington · Seattle, Washington · NCT07224100

• Dose‑adjusted EPOCH chemotherapy with or without rituximab plus ponatinib for newly diagnosed Philadelphia chromosome–positive B‑cell ALL/lymphoblastic lymphoma

  This treatment plan tests whether adding the BCR‑ABL inhibitor ponatinib to dose‑adjusted EPOCH chemotherapy, with rituximab for CD20‑positive disease, helps adults newly diagnosed with Philadelphia chromosome–positive B‑cell acute lymphoblastic leukemia or lymphoblastic lymphoma.

  Recruiting Phase 2 University of Washington · Seattle, Washington · NCT07224100

• Asciminib as maintenance after cellular therapies for Ph+ ALL

  This phase 1 study tests whether maintenance with asciminib is safe and tolerable for adults with Philadelphia chromosome–positive ALL after HSCT or CAR-T therapy.

  Recruiting Phase 1 City of Hope Medical Center · Duarte, California · NCT07040982

• Personalized NK cell therapy after umbilical cord blood transplant for leukemia

  This study is testing if a special treatment using personalized immune cells from umbilical cord blood can help people with leukemia feel better after their transplant.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT02727803

• Using inotuzumab ozogamicin with chemotherapy to treat acute lymphoblastic leukemia

  This study is testing if a new drug combined with lighter chemotherapy can help older patients with acute lymphoblastic leukemia who can't handle stronger treatments.

  Recruiting Phase 1/2 M.D. Anderson Cancer Center · Houston, Texas · NCT01371630

Related topics

Quick answers

How many q11.2) clinical trials are recruiting right now?

5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →